AU3570195A - Pharmaceutical composition of fantofarone for oral administration - Google Patents
Pharmaceutical composition of fantofarone for oral administrationInfo
- Publication number
- AU3570195A AU3570195A AU35701/95A AU3570195A AU3570195A AU 3570195 A AU3570195 A AU 3570195A AU 35701/95 A AU35701/95 A AU 35701/95A AU 3570195 A AU3570195 A AU 3570195A AU 3570195 A AU3570195 A AU 3570195A
- Authority
- AU
- Australia
- Prior art keywords
- fantofarone
- pharmaceutical composition
- oral administration
- oral
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9411755 | 1994-09-30 | ||
FR9411755A FR2725133B1 (en) | 1994-09-30 | 1994-09-30 | PHARMACEUTICAL COMPOSITION OF FANTOFARONE FOR ORAL ADMINISTRATION |
PCT/FR1995/001245 WO1996010406A1 (en) | 1994-09-30 | 1995-09-27 | Pharmaceutical composition of fantofarone for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3570195A true AU3570195A (en) | 1996-04-26 |
Family
ID=9467485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU35701/95A Abandoned AU3570195A (en) | 1994-09-30 | 1995-09-27 | Pharmaceutical composition of fantofarone for oral administration |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU3570195A (en) |
FR (1) | FR2725133B1 (en) |
WO (1) | WO1996010406A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57140713A (en) * | 1981-02-25 | 1982-08-31 | Nippon Chemiphar Co Ltd | Novel preventing agent and remedy for allergic disease |
FR2594438B1 (en) * | 1986-02-14 | 1990-01-26 | Labaz Sanofi Nv | INDOLIZINE DERIVATIVES, THEIR PREPARATION PROCESS AND THE COMPOSITIONS CONTAINING SAME |
IL87181A (en) * | 1987-08-07 | 1993-08-18 | Sanofi Sa | Aminoalkoxyphenyl derivatives, their preparation and pharmaceutical and veterinary compositions containing them |
-
1994
- 1994-09-30 FR FR9411755A patent/FR2725133B1/en not_active Expired - Fee Related
-
1995
- 1995-09-27 WO PCT/FR1995/001245 patent/WO1996010406A1/en active Application Filing
- 1995-09-27 AU AU35701/95A patent/AU3570195A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
FR2725133A1 (en) | 1996-04-05 |
WO1996010406A1 (en) | 1996-04-11 |
FR2725133B1 (en) | 1996-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL115097A0 (en) | Pharmaceutical compositions adapted for oral administration | |
AU7052798A (en) | Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates | |
AU7052698A (en) | Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates | |
AU762322C (en) | Novel galenic formulations of meloxicam for oral administration | |
AU2638297A (en) | Oral pharmaceutical preparation containing ibandronat | |
AU5402296A (en) | Pharmaceutical composition for transdermic administration | |
EP0873749A4 (en) | Jellied medicinal composition for oral administration | |
IL118637A0 (en) | Oral pharmaceutical compositions of S(+)-ibuprofen | |
AU4010395A (en) | Compositions for increased bioavailability of orally delivered therapeutic agents | |
AU5157590A (en) | Pharmaceutical compositions for oral administration | |
AU7294196A (en) | Stable pharmaceutical forms of administration containing parathormone | |
IL118636A (en) | Oral pharmaceutical compositions of S(+)-etodolac | |
AU1689999A (en) | Medicinal composition for percutaneous administration | |
AU4560297A (en) | Pharmaceutical microspheres of valproic acid for oral administration | |
AU5811996A (en) | Nanoparticles for oral administration of pharmaceutical agen ts of low solubility | |
AU7420494A (en) | Rapamycin formulations for oral administration | |
IL114673A (en) | Pharmaceutical compositions containing protein for oral administration | |
AU1354495A (en) | Formulations for orally administered pharmaceutical agents | |
IL115125A0 (en) | Pharmaceutical formulations comprising derivatives of clavulanic acid | |
AU7735798A (en) | Pharmaceutical composition for oral administration | |
AU8015398A (en) | Pharmaceutical formulations containing colostrum and the use of colostrum for the treatment of affections of the oral cavity | |
NZ307370A (en) | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form | |
AU5347996A (en) | Preparation for oral administration | |
AU3570195A (en) | Pharmaceutical composition of fantofarone for oral administration | |
AU3860797A (en) | Pharmaceutical formulations for oral administration |